Overview/Description
Ulema Inc. is a market research firm providing consulting, market analysis, strategic planning and technology forecasting services. The Ulema Reports Group (URG), a wholly owned subsidiary of Ulema Inc., produces single and multi-client studies on fast moving market sectors. The lifecycles for these studies are often as little as 6 months to one year from the start of development, so in order remain profitable, the company relies on a highly skilled research and production staff to collate data, analyze markets, and write reports with extremely short turn-around times. More often than not, these studies are pre-marketed, so late deliveries or aborted projects can be quite costly.
URG has experienced dramatic growth over the past three years. Through aggressive hiring, production staff has been increased by 50%. However, due to the high demands of the job, the average retention rate for a research analyst is two years, and URG is constantly recruiting.
You are the VP and Principal Analyst for Pharmaceutical and Biotechnology Services. Two team leaders report to you: Dana Ferris, responsible for the drug development market and Joe Makato for the industrial biotech market.
In this simulation, the second of two in the series, you have already successfully obtained management buy-in for a planned succession program. However, you also know that the CEO is planning a major expansion effort, which makes a strong program even more crucial. How you implement the plan will determine its success.
You must develop an action plan, assess current and future work requirements, identify and prepare potential successors, and finally announce the plan in a general meeting.
This simulation is made up of five scenarios and contains links to the following SkillSoft courses: LEAD0301, LEAD0302, LEAD0303, and LEAD0304.
Target Audience
Managers and executives concerned about information and business continuity on a departmental level or organization-wide.